FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicinal agents and to pharmaceutical composition for prevention or treatment of cardiovascular diseases, including pharmacologically efficient amount of a) daglutril and/or its physiologically compatible salts and b) hydrochlorotiaside or its any physiologically compatible tautomers, salts, solvates or esters. Also application of daglutril in combination with hydrochlorotiaside is described to make medicinal agent for prophylactics or treatment of cardiovascular diseases, as well as set for prophylactics or treatment of cardiovascular diseases.
EFFECT: composition according to invention demonstrates synergetic effect in treatment of cardiovascular diseases.
11 cl, 1 tbl, 1 ex
Authors
Dates
2011-01-20—Published
2006-02-17—Filed